New Developments in the Use of Prostatic Stents

Overview

Journal Open Access J Urol

Publisher Dove Medical Press

Specialty Urology

Date 2013 Nov 8

PMID 24198637

Citations 8

Authors

Athanasios G Papatsoris

Islam Junaid

Alexandra Zachou

Stefanos Kachrilas

Faruquz Zaman

Junaid Masood

Noor Buchholz

Affiliations

Soon will be listed here.

Abstract

Bladder outflow obstruction is a very common age-related clinical entity due to a variety of benign and malignant diseases of the prostate. Surgical treatment under general or regional anesthesia is not suitable for high-risk elderly patients who seek minimally invasive management. Unfortunately, for patients who are not fit for transurethral and/or laser prostatectomy, few treatment options remain, other than long-term catheterization and insertion (under local anesthesia) of a prostatic stent. In this review, we present developments in the use of prostatic stents.

Citing Articles

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia.

Lama J, Winograd J, Codelia-Anjum A, Bhojani N, Elterman D, Zorn K Curr Urol Rep. 2024; 26(1):9.

PMID: 39373947 DOI: 10.1007/s11934-024-01235-3.

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years - A Review of Published Literature.

Codelia-Anjum A, Berjaoui M, Khondker A, Elterman D, Zorn K, Bhojani N Clin Interv Aging. 2023; 18:1705-1717.

PMID: 37849957 PMC: 10577238. DOI: 10.2147/CIA.S414799.

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Woo H, Huang C, Huang W, Chang Y, Lien C, Chkhotua A Prostate Cancer Prostatic Dis. 2022; 25(3):576-582.

PMID: 35641601 PMC: 9385491. DOI: 10.1038/s41391-022-00548-z.

The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.

Roehrborn C, Chin P, Woo H Prostate Cancer Prostatic Dis. 2021; 25(1):79-85.

PMID: 34363010 PMC: 9018420. DOI: 10.1038/s41391-021-00434-0.

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy.

Srinivasan A, Wang R World J Mens Health. 2019; 38(4):402-411.

PMID: 31496146 PMC: 7502324. DOI: 10.5534/wjmh.190076.

References

Tomschi W, Luftenegger W . [The urological spiral. A real alternative to the indwelling catheter? Experience in 23 patients]. Wien Klin Wochenschr. 1990; 102(21):650-3. View

Markovic B, Markovic Z, Yachia D, Hadzi D . [A new generation of urethral stents--Allium in the therapy of symptomatic prostatic enlargement of various etiology]. Acta Chir Iugosl. 2007; 54(3):71-6. DOI: 10.2298/aci0703071m. View

De Vocht T, van Venrooij G, Boon T . Self-expanding stent insertion for urethral strictures: a 10-year follow-up. BJU Int. 2003; 91(7):627-30. DOI: 10.1046/j.1464-410x.2003.04200.x. View

Yoon C, Song H, Kim J, Park H, Kang H, Ro J . Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates. J Vasc Interv Radiol. 2010; 21(9):1429-35. DOI: 10.1016/j.jvir.2010.05.013. View

Madersbacher S, Alivizatos G, Nordling J, Rioja Sanz C, Emberton M, de la Rosette J . EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004; 46(5):547-54. DOI: 10.1016/j.eururo.2004.07.016. View

Minagawa T, Murata Y, Seki S . [Placement of a shape-memory alloy intraurethral catheter (Memokath) using transrectal ultrasonography and fluoroscopy]. Nihon Hinyokika Gakkai Zasshi. 2009; 100(3):508-12. DOI: 10.5980/jpnjurol.100.508. View

Song H, Cho K, Sung K, Han Y, Kim Y, Kim C . Self-expandable metallic stents in high-risk patients with benign prostatic hyperplasia: long-term follow-up. Radiology. 1995; 195(3):655-60. DOI: 10.1148/radiology.195.3.7538681. View

van Dijk M, Mochtar C, Wijkstra H, Laguna M, de la Rosette J . The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol. 2006; 49(2):353-9. DOI: 10.1016/j.eururo.2005.12.008. View

MEBUST W . Transurethral prostatectomy. Urol Clin North Am. 1990; 17(3):575-85. View

10.

Kotsar A, Isotalo T, Juuti H, Mikkonen J, Leppiniemi J, Hanninen V . Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. BJU Int. 2008; 103(5):626-9. DOI: 10.1111/j.1464-410X.2008.08111.x. View

11.

Kulkarni R . Metallic ureteric stents: the current situation. BJU Int. 2003; 92(3):188-9. DOI: 10.1046/j.1464-410x.2003.04335.x. View

12.

Staios D, Shergill I, Thwaini A, Junaid I, Buchholz N . The Memokath stent. Expert Rev Med Devices. 2007; 4(2):99-101. DOI: 10.1586/17434440.4.2.99. View

13.

Grimsley S, Khan M, Lennox E, Paterson P . Experience with the spanner prostatic stent in patients unfit for surgery: an observational study. J Endourol. 2007; 21(9):1093-6. DOI: 10.1089/end.2006.0254. View

14.

Yachia D, Aridogan I . Comparison between first-generation (fixed-caliber) and second-generation (self-expanding, large caliber) temporary prostatic stents. Urol Int. 1996; 57(3):165-9. DOI: 10.1159/000282903. View

15.

Henderson A, Laing R, Langley S . A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy. Brachytherapy. 2004; 1(4):211-8. DOI: 10.1016/S1538-4721(02)00100-9. View

16.

Carl J, Nielsen J, Holmberg M, Larsen E, Fabrin K, Fisker R . Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol. 2010; 50(4):547-54. DOI: 10.3109/0284186X.2010.541935. View

17.

Masood S, Djaladat H, Kouriefs C, Keen M, Palmer J . The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. 2004; 94(9):1271-4. DOI: 10.1111/j.1464-410X.2004.05155.x. View

18.

Knutson T . Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases?. Curr Opin Urol. 2004; 14(1):35-9. DOI: 10.1097/00042307-200401000-00008. View

19.

Roehrborn C . Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am. 2010; 95(1):87-100. DOI: 10.1016/j.mcna.2010.08.013. View

20.

van Dijk M, Mochtar C, Wijkstra H, Laguna M, de la Rosette J . Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Urology. 2005; 66(4):845-9. DOI: 10.1016/j.urology.2005.04.030. View